Literature DB >> 32685548

Integrated Role of Nonpharmacological Interventions for Rehabilitation of Individuals with Musculoskeletal Disorders.

Mario Bernardo-Filho1, Borja Sañudo2, Adérito Seixas3, Danúbia Sá-Caputo1, Redha Taiar4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32685548      PMCID: PMC7330636          DOI: 10.1155/2020/9493623

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


× No keyword cloud information.
Nonpharmacological interventions (NPI) include any treatment without drug treatment without medication such as physical activity and psychosocial interventions (speech-based therapies). These methods have a preventive or therapeutic action and aim to prevent, treat, or cure health problems. It takes the form of a product, method, and program or service whose content must be known by the user, and it is related to biological mechanisms and/or psychological processes. Among them, various technical procedures related to (i) physiotherapy (hand manipulations, electromagnetic radiations, and electrical and ultrasound sources), ((iii) assistive devices, (iv) psychotherapy and behavioral actions (habits in general and nutrition), (v) occupational therapy, (vi) speech and language therapy, and (vii) complementary and alternative medicine [1]. Moreover, physical exercises and vibratory therapy such as segmental and whole-body vibration exercises might be included among the NPI. In fact, various populations including the elderly with different clinical disorders have been submitted to these interventions. It is important to highlight that nonpharmacological and pharmacological therapies are complementary on the management of the elderly with clinical conditions, often with multimorbidity. It is widely acknowledged that NPI, including surgery, can be effective and sometimes more effective than pharmacological therapy in the treatment of several common, chronic, and undesirable conditions [2, 3] Indeed, [4] consider that NPI in older people can be just as important as pharmacological therapies to treat chronic conditions. It is suggested that ageing populations would require more and more relief from chronic pain and disability and that the prevalence of musculoskeletal disorders (MSDs) will continue to rise [5, 6]. Moreover, MSDs consume a large amount of health and social resources and are a major cause of disability in both low- and high-income countries [7]. MSDs are undesirable multifactorial clinical conditions affecting different human body parts and are the leading cause of years lived with disability in the world affecting children, working age population, and elderly. Although not fatal, these conditions have a high prevalence and significant impact on daily living activities by limiting and restricting the participation of individuals affecting them and society. In addition, individuals with several diseases such as spinal cord injury, cerebral palsy, and stroke are more prone to develop MSDs. Otherwise, there is a widespread underuse of nonpharmacological therapies on the management of chronic diseases and associated clinical conditions of the elderly. Considering that the prevalence of these conditions is expected to increase in the coming years due to ageing, rising levels of obesity, and physical inactivity, there is a clear demand in research focusing on the rehabilitation of MSDs. Putting together the previous rationale, the challenges and reflections in organizing this special issue, we thank the Hindawi publisher for the confidence. A special thanks to all authors that contributed in this special issue of the journal Biomedical Research International entitled “Integrated Role of Nonpharmacological Interventions for Rehabilitation of Individuals with Musculoskeletal Disorders.” The authors tried to bring a useful issue involving the proper use of NPI for the rehabilitation of individuals having musculoskeletal disorders. They contributed by giving scientific evidence and disseminated the knowledge about the benefits and the plurality of NPI and the management of the MSDs. The aim was to provide a multidisciplinary discussion forum covering all rehabilitation professions regarding the integrated role of NPI in the aim to reduce the burden of individuals living with MSDs. The readers will find scientific information about the integrated role of NPI for MSDs in the elderly, sports, and special populations (e.g., pregnant women, cancer patients, and others) and strategies to avoid and manage musculoskeletal disorders in the workplace and prevention of MSDs across all lifespans and settings.
  6 in total

1.  Evidence of and recommendations for non-pharmacological interventions for common geriatric conditions: the SENATOR-ONTOP systematic review protocol.

Authors:  Iosief Abraha; Alfonso Cruz-Jentoft; Roy L Soiza; Denis O'Mahony; Antonio Cherubini
Journal:  BMJ Open       Date:  2015-01-27       Impact factor: 2.692

2.  Poor description of non-pharmacological interventions: analysis of consecutive sample of randomised trials.

Authors:  Tammy C Hoffmann; Chrissy Erueti; Paul P Glasziou
Journal:  BMJ       Date:  2013-09-10

3.  Improvements in health-related quality of life and function in middle-aged women with chronic diseases of lifestyle after participating in a non-pharmacological intervention programme: A pragmatic randomised controlled trial.

Authors:  Roline Y Barnes; Jennifer Jelsma; Romy Parker
Journal:  Afr J Disabil       Date:  2019-02-25

Review 4.  Exercise-based rehabilitation for heart failure.

Authors:  Rod S Taylor; Viral A Sagar; Ed J Davies; Simon Briscoe; Andrew J S Coats; Hayes Dalal; Fiona Lough; Karen Rees; Sally Singh
Journal:  Cochrane Database Syst Rev       Date:  2014-04-27

Review 5.  Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study.

Authors:  Huseyin Naci; John P A Ioannidis
Journal:  BMJ       Date:  2013-10-01

6.  Musculoskeletal conditions may increase the risk of chronic disease: a systematic review and meta-analysis of cohort studies.

Authors:  Amanda Williams; Steven J Kamper; John H Wiggers; Kate M O'Brien; Hopin Lee; Luke Wolfenden; Sze Lin Yoong; Emma Robson; James H McAuley; Jan Hartvigsen; Christopher M Williams
Journal:  BMC Med       Date:  2018-09-25       Impact factor: 8.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.